Índice cintura cadera y peso de adenoma prostático

Mario Alberty Chávez Gil, Jorge Christian Luna Abanto

Texto completo:

HTML PDF

Resumen

Introducción: la hiperplasia prostática benigna (HPB) y la obesidad son problemas de salud prevalentes en hombres mayores.
Objetivo: determinar la existencia de correlación entre el índice cintura cadera (ICC) y peso de adenoma prostático.
Material y métodos: 34 pacientes fueron evaluados, se midió la circunferencia de cintura y cadera según el protocolo de la Organización Mundial de Salud (OMS) en el preoperatorio y se registró el peso del adenoma prostático enucleado en sala de operaciones.
Resultados: la edad media de los participantes fue 70 años, el índice cintura cadera medio fue 0.99, el peso medio del adenoma enucleado fue 54.38 g. Entre las variables Índice cintura cadera y peso de adenoma se encontró correlación inversa (r:-0.179); sin embargo, esta correlación es débil (r2: 0.03) y no significativa (p: 0.312).
Conclusión: no se encontró correlación entre el índice cintura cadera y el peso de adenoma prostático.

Palabras clave: hiperplasia prostática benigna, índice cintura cadera, próstata, obesidad.

ABSTRACT

Introduction: Benign prostatic hyperplasia (BPH) and obesity are prevalent health problems in older men.
Objective: the aim of this study is to determine the existence of correlation between waist-hip ratio and the prostatic adenoma weight.
Material and Methods: 34 patients were enrolled, measurements of waist and hip circumference were performed before surgery according to the World Health Organization (WHO) protocol and the enucleated prostatic adenoma was weighed in the operating room.
Results: the average age of participants was 70 years, the average waist-hip ratio was 0.99, and the average weight of the enucleated adenoma was 54.38 g. Among the variables waist-hip ratio and weight of adenoma inverse correlation was found (r: -0.179), however this correlation is weak (r2: 0.03) and not significant (p: 0.312).
Conclusion: no correlation between waist-hip ratio and the weight of prostatic adenoma was found.

Key words: Benign prostatic hyperplasia, waist hip ratio, prostate, obesity.

Referencias

J.M. Cózar-Olmoa, C. Hernández-Fenández, B. Minana-López, J.H. Amón-Sesmero. Consensus on the clinical impact of the new scientific evidence available on benign prostatic hiperplasia. Actas Urol Esp. 2012; 36(5):265-275.

Marie E. Duncan and Michael J. Goldacre. Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979–2006. BJU International. 2011, 107: 40–45.

Nishant D. Patel and J. Kellogg Parsons. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014 Apr-Jun; 30(2): 170–176.

Benign Prostatic Hyperplasia: American Urological Association revised 2010 [Internet]. [citado 18 de julio de 2013]. Disponible en: http://goo.gl/UUkni

Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132(3):474.

Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990; 17(3):241.

Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001; 54(9):935.

G. Messele Getahun, A. Getachew Kebede. Comparison of prostatic volume measured with abdominal ultrasound and prostatic weight determined after open enucleation performed in Gondar University Hospital, Ethiopia. African Journal of Urology. September 2008, Volume 14, Issue 2, pp 86-89.

Ng Kent Hoo, Muhammad Akmal Ayob, Maheza Irna Mohamad Salim, Heamn Noori Abduljabbar, Eko Supriyanto. Prostate Volume Measurement Using Transabdominal Ultrasound Scanning. Advances in Environment, Biotechnology and Biomedicine. 2012; ISBN: 978-1-61804-122-7.

Hee Jo Yang, Seung Whan Doo, Won Jae Yang and Yun Seob Song. Which Obesity Index Best Correlates With Prostate Volume, Prostate-specific Antigen, and Lower Urinary Tract Symptoms?. Urology. 2012; 80(1):187-190.

Soygür T, Küpeli B, Aydos K, et al. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol.1996; 28:55-59.

Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006; 91:2562-2568.

Lee S, Min HG, Choi SH, et al. Central obesity as a risk factor for prostatic hyperplasia. Obes Silver Spring. 2006; 14:172-179.

Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol. 1994; 140:989-1002.

JH Fowke, SS Motley, MS Cookson, R Concepcion, SS Chang, ML Wills, et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer and Prostatic Diseases. 2007; 10, 137–142.

Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991; 40:101-104.

Majed S. Alokail, Nasser M. Al-Daghri, Omar S. Al-Attas, Khalid M. Alkharfy, Shaun B. Sabico and Axel Ullrich. Visceral obesity and inflammation markers in relation to serum prostate volume biomarkers among apparently healthy men. European Journal of Clinical Investigation. 2011; Vol 41 987-994.

Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114:1752-1761.

Yee CH, So WY, Yip SKh, Wu E, Yau P, Ng CF. Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: A randomized controlled trial. Korean J Urol. 2015 Mar; 56(3):240-247.

Parsons JK1, Messer K, White M, Barrett-Connor E, Bauer DC, Marshall LM. Osteoporotic Fractures in Men (MrOS) Research Group and the Urologic Diseases in America Project. Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol. 2011 Dec; 60(6):1173-80.

Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006; 91: 2562–2568.

Burke JP, Rhodes T, Jacobson DJ et al: Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 2006; 164: 41.

Fritschi L, Tabrizi J, Leavy J et al: Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 2007; 121: 781.

Hsu-Han Wang, Chi-Jeng Hsiehc, Kuo-Jen Lina, Sheng-Hsien Chua, Cheng-Keng Chuang, Hsiao-Wen Chena, et al. Waist circumference is an independent risk factor for prostatic hyperplasia in Taiwanese males. Asian Journal of Surgery. 2011; Vol 34(4):163-167.

Aguilar-Barradas J, García-Irigoyen C, Manzanilla-García HA, Castro-Ibarra M, Martínez-Hernández MC, Acevedo-García C. Estudio correlacional entre el índice de masa corporal, perímetro abdominal y volumen de la glándula prostática en pacientes con sintomatología obstructiva urinaria por crecimiento prostático. Revista Mexicana de Urologia. 2010; 70(3):141-145.

World Health Organization. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. Reporte. Geneva, 8–11 December 2008.

Auda Hassan Ali Al.Jabbiri, Mohanad M.H. Al-Saedi, Usama S. Al.Nasiri. Correlations between Preoperative Measurement of Prostate Volume by Transabdominal and Transrectal Ultrasound with Open Prostatectomy. The Iraqi Postgraduate Medical Journal. 2012; Vol 11, N°4: 569-574.

Relación entre variables cuantitativas [Internet]. [citado 30 de Enero de 2015]. Disponible en: http://goo.gl/sbceQ

Pautas Éticas Internacionales para la Investigación y Experimentación Biomédica en Seres Humanos de la Organización Mundial de la Salud Ginebra 2002. [citado 30 de Enero de 2015]. Disponible en: http://goo.gl/7daVC

Centro Nacional de Alimentación y Nutrición, Instituto Nacional de Salud. Sala Situacional Alimentaria Nutricional 5: Sobrepeso Y Obesidad. 2013. Disponible en: http://goo.gl/KrFToL

Tewari R, Rajender S, Natu SM, Dalela D, Goel A, Goel MM, et al. Diet, obesity, and prostate health: are we missing the link? J Androl. 2012 Sep-Oct; 33(5):763-76.

Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007 Aug; 178(2):395-401.

Hammarsten J, Högstedt B, Holthuis N, Mellström D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998; 1:157-62.

Cosimo De Nunzio, William Aronson, Stephen J. Freedland, Edward Giovannucci, J. Kellogg Parsons. The Correlation Between Metabolic Syndrome and Prostatic Diseases. Eur Urol. 2012 Mar; 61(3):560-70.



Añadir comentario